|Robert Blum||Investor Relations|
|Jan D'Alvise||President and Chief Executive Officer|
|Brian Ford||Chief Financial Officer|
|Monique Champagne||Vice President, Clinical Affairs|
Good day, and welcome to the Acasti Pharma Fourth Quarter and Fiscal Year 2022 Financial Results Conference Call. All participants will be in listen-only mode. [Operator Instructions] After today's presentation, there will be an opportunity to ask questions. [Operator Instructions] Please note this event is being recorded. I would now like to turn the conference over to Robert Blum of Lytham Partners.